Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05804240 · ClinicalTrials.gov registry record
TEE 3D RV Assessment for SAVR, Mini AVR, and TAVR
A clinical trial of Right Ventricular Dysfunction, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- 78
- Enrollment target
- 1
- Study location
NCT05804240: Recruiting study of Right Ventricular Dysfunction, sponsored by Thomas Jefferson University.
NCT05804240 is a study of Right Ventricular Dysfunction that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 78 participants, below the 227-participant average among 5 other Right Ventricular Dysfunction trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05804240, a study of Right Ventricular Dysfunction, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
Three-dimensional echocardiography has become a gold standard to assess right ventricular (RV) function, and investigators plan to use 3D transesophageal echocardiography to assess RV function in 3 types of aortic valve replacement (AVR): surgical AVR (SAVR), mini-sternotomy AVR (mini AVR), and transcatheter AVR (TAVR).
Primary Outcome
RVEF assessed using 3D TEE at baseline
Conditions Studied
Interventions
- DIAGNOSTIC_TEST 3D TEE RVEF
Study Locations (1)
Pennsylvania
- Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2025-06-30 |
What NCT05804240 shows while recruiting
NCT05804240 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 227-participant average among 5 other Right Ventricular Dysfunction trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Right Ventricular Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which 3D TEE RVEF is the first listed.
NCT05804240 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05804240 about?
NCT05804240 is a clinical study titled "TEE 3D RV Assessment for SAVR, Mini AVR, and TAVR". Three-dimensional echocardiography has become a gold standard to assess right ventricular (RV) function, and investigators plan to use 3D transesophageal echocardiography to assess RV function in 3 types of aortic valve replacement (AVR): surgical AVR (SAVR), mini-sternotomy AVR (mini AVR), and tran...
What is the current status of trial NCT05804240?
This trial is currently recruiting. The enrollment target is 78 participants. The study started on 2023-04-01. Estimated completion is 2025-06-30.
What conditions does trial NCT05804240 study?
This clinical trial studies the following conditions: Right Ventricular Dysfunction.
What interventions are being tested in trial NCT05804240?
The interventions under investigation include: 3D TEE RVEF (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05804240?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05804240 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Right Ventricular Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Repurposing Valsartan May Protect Against Pulmonary Hypertension
RECRUITING · Phase 2
-
Identifying Right Ventricular Dysfunction in COPD Through Right Heart Catheterization, Imaging and Exercise
RECRUITING · NA
-
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE
ACTIVE NOT RECRUITING · Phase 4
-
Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study
COMPLETED · Phase 1
-
A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI